Oruka Therapeutics, Inc.
ORKA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000907654
In the last 90 days, Oruka Therapeutics, Inc. insiders filed 0 open-market purchases and 16 sales; 255 institutions reported holding it in 13F filings for Q2 2026, worth $7.05B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Oruka Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +11 vs. Q2 2024
- Shares held
- 24.6M
- +11.9M (+93.8%) vs. Q2 2024
- Total value
- $604.2M
- +$555.7M (+1,146.4%) vs. Q2 2024
- New holders
- 24
- 6 more added
- Sold out
- 13
- 12 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORKA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 255 | $7.05B |
| Q1 2026 | 184 | $2.55B |
| Q4 2025 | 143 | $1.60B |
| Q3 2025 | 105 | $875.8M |
| Q2 2025 | 81 | $386.0M |
| Q1 2025 | 71 | $326.1M |
| Q4 2024 | 66 | $606.6M |
| Q3 2024 | 42 | $604.2M |
| Q2 2024 | 32 | $49.4M |
| Q1 2024 | 23 | $12.7M |
| Q4 2023 | 25 | $12.7M |
| Q3 2023 | 21 | $6.55M |
| Q2 2023 | 23 | $5.75M |
| Q1 2023 | 26 | $5.02M |
| Q4 2022 | 22 | $6.19M |
| Q3 2022 | 25 | $4.58M |
| Q2 2022 | 24 | $4.17M |
| Q1 2022 | 22 | $2.60M |
| Q4 2021 | 21 | $2.41M |
| Q3 2021 | 19 | $4.53M |
| Q2 2021 | 17 | $4.16M |
| Q1 2021 | 17 | $3.20M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Oruka Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 4,682,300 | $114.8M | 0.01% | +4,682,300 | New |
| Fairmount Funds Management LLC | 3,211,922 | $78.7M | 6.38% | +3,211,922 | New |
| VR Adviser, LLC | 3,085,620 | $75.6M | 3.96% | +2,219,245+256.2% | Added |
| RTW Investments, LP | 1,850,648 | $45.4M | 0.66% | +450,648+32.2% | Added |
| Commodore Capital LP | 1,369,714 | $33.6M | 2.10% | +955,389+230.6% | Added |
| Perceptive Advisors LLC | 1,235,187 | $30.3M | 0.65% | +1,235,187 | New |
| Deep Track Capital, LP | 1,235,187 | $30.3M | 0.97% | +1,235,187 | New |
| Franklin Resources Inc | 720,547 | $20.0M | 0.01% | +720,547 | New |
| Avidity Partners Management LP | 790,926 | $19.4M | 0.99% | −209,074−20.9% | Reduced |
| Paradigm Biocapital Advisors LP | 719,660 | $17.6M | 0.62% | +719,660 | New |
| Braidwell LP | 515,726 | $12.6M | 0.36% | +515,726 | New |
| Great Point Partners LLC | 514,659 | $12.6M | 3.81% | +514,659 | New |
| Point72 Asset Management, L.P. | 482,330 | $11.8M | 0.04% | +482,330 | New |
| Frazier Life Sciences Management, L.P. | 477,327 | $11.7M | 0.47% | +477,327 | New |
| Redmile Group, LLC | 411,728 | $10.1M | 0.59% | +411,728 | New |
| Woodline Partners LP | 390,795 | $9.58M | 0.08% | +390,795 | New |
| Sr One Capital Management, LP | 375,330 | $9.20M | 1.84% | +375,330 | New |
| Affinity Asset Advisors, LLC | 349,836 | $8.57M | 1.33% | +277,352+382.6% | Added |
| Cable Car Capital LLC | 333,371 | $8.17M | 8.81% | −3,667,081−91.7% | Reduced |
| Driehaus Capital Management LLC | 308,795 | $7.57M | 0.06% | +308,795 | New |
| Price T Rowe Associates Inc | 279,648 | $6.86M | 0.00% | +279,648 | New |
| Logos Global Management LP | 257,330 | $6.31M | 0.71% | +257,330 | New |
| Janus Henderson Group PLC | 236,116 | $5.84M | 0.00% | −1,146,620−82.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 200,000 | $4.90M | 0.01% | −1,000,000−83.3% | Reduced |
| TD Asset Management Inc | 95,076 | $2.17M | 0.00% | +95,076 | New |
| Wellington Management Group LLP | 82,137 | $2.01M | 0.00% | +82,137 | New |
| Morgan Stanley | 68,133 | $1.67M | 0.00% | −581,867−89.5% | Reduced |
| Cowen and Company, LLC | 58,332 | $1.43M | 0.05% | −641,668−91.7% | Reduced |
| Manufacturers Life Insurance Company, The | 42,298 | $1.04M | 0.00% | +42,298 | New |
| Qube Research & Technologies Ltd | 41,360 | $1.01M | 0.00% | +41,310+82,620.0% | Added |
| Vanguard Group Inc | 37,798 | $926.4K | 0.00% | −415,800−91.7% | Reduced |
| Citigroup Inc | 26,720 | $654.9K | 0.00% | +26,720 | New |
| Ensign Peak Advisors, Inc | 25,000 | $612.8K | 0.00% | +25,000 | New |
| BlackRock, Inc. | 21,567 | $528.6K | 0.00% | +21,567 | New |
| Geode Capital Management, LLC | 13,984 | $342.8K | 0.00% | −147,751−91.4% | Reduced |
| ADAR1 Capital Management, LLC | 11,187 | $274.2K | 0.05% | −73,489−86.8% | Reduced |
| Tower Research Capital LLC (TRC) | 965 | $23.7K | 0.00% | +621+180.5% | Added |
| Activest Wealth Management | 166 | $4.07K | 0.00% | −1,834−91.7% | Reduced |
| New England Capital Financial Advisors LLC | 41 | $1.00K | 0.00% | +41 | New |
| Parallel Advisors, LLC | 20 | $490 | 0.00% | −224−91.8% | Reduced |
| Bank of America Corp | 15 | $368 | 0.00% | −136−90.1% | Reduced |
| Danske Bank A/S | 2 | $49 | 0.00% | +2 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −73,099−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −59,707−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −42,502−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −32,461−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −27,779−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −20,982−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −14,988−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −7,131−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −3,985−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | 0 | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |